In vitro-in vivo-in silico approach in biopharmaceutical characterization of ibuprofen IR and SR tablets
Abstract
Within the last decades, physiologically based pharmacokinetic models have emerged into a biopharmaceutical toolkit that has been proven useful in understanding how physicochemical, formulation and physiological factors affect oral drug absorption. The purpose of this study was to develop a drug specific physiologically based pharmacokinetic model that will allow mechanistic interpretation of oral absorption from dosage forms exhibiting different in vitro and different in vivo performance (i.e. immediate release and sustained release tablets) and identification of bioperformance dissolution testing. Ibuprofen was chosen to be used for the "proof of concept" considering it is well characterised and the necessary physicochemical, biopharmaceutical and pharmacokinetic properties for model development could be found in the literature. Gastrointestinal simulation technology implemented in Simcyp (R) was successful in estimating ibuprofen oral absorption. The developed model exhibited good g...eneralisation ability for the dosage forms studied. The obtained results indicate that the model was sensitive to input kinetics represented by the in vitro drug release profiles obtained under various dissolution conditions. According to the obtained results, reciprocating cylinder apparatus with biorepresentative change in media pH might be considered as bioperformance dissolution in the case of the two ibuprofen SR products studied. These results further justify the use of integrated in vitro-in vivo-in silico approach in estimating bioperformance of oral solid dosage forms.
Keywords:
Bioperformance dissolution / Gastrointestinal simulation / In vitro-in vivo-in silica approach / IbuprofenSource:
European Journal of Pharmaceutical Sciences, 2015, 75, 151-159Publisher:
- Elsevier Science BV, Amsterdam
Funding / projects:
DOI: 10.1016/j.ejps.2015.03.027
ISSN: 0928-0987
PubMed: 25861718
WoS: 000356552500016
Scopus: 2-s2.0-84929706296
Collections
Institution/Community
PharmacyTY - JOUR AU - Beloica, Sofija AU - Cvijić, Sandra AU - Bogataj, Marija AU - Parojčić, Jelena PY - 2015 UR - https://farfar.pharmacy.bg.ac.rs/handle/123456789/2464 AB - Within the last decades, physiologically based pharmacokinetic models have emerged into a biopharmaceutical toolkit that has been proven useful in understanding how physicochemical, formulation and physiological factors affect oral drug absorption. The purpose of this study was to develop a drug specific physiologically based pharmacokinetic model that will allow mechanistic interpretation of oral absorption from dosage forms exhibiting different in vitro and different in vivo performance (i.e. immediate release and sustained release tablets) and identification of bioperformance dissolution testing. Ibuprofen was chosen to be used for the "proof of concept" considering it is well characterised and the necessary physicochemical, biopharmaceutical and pharmacokinetic properties for model development could be found in the literature. Gastrointestinal simulation technology implemented in Simcyp (R) was successful in estimating ibuprofen oral absorption. The developed model exhibited good generalisation ability for the dosage forms studied. The obtained results indicate that the model was sensitive to input kinetics represented by the in vitro drug release profiles obtained under various dissolution conditions. According to the obtained results, reciprocating cylinder apparatus with biorepresentative change in media pH might be considered as bioperformance dissolution in the case of the two ibuprofen SR products studied. These results further justify the use of integrated in vitro-in vivo-in silico approach in estimating bioperformance of oral solid dosage forms. PB - Elsevier Science BV, Amsterdam T2 - European Journal of Pharmaceutical Sciences T1 - In vitro-in vivo-in silico approach in biopharmaceutical characterization of ibuprofen IR and SR tablets VL - 75 SP - 151 EP - 159 DO - 10.1016/j.ejps.2015.03.027 ER -
@article{ author = "Beloica, Sofija and Cvijić, Sandra and Bogataj, Marija and Parojčić, Jelena", year = "2015", abstract = "Within the last decades, physiologically based pharmacokinetic models have emerged into a biopharmaceutical toolkit that has been proven useful in understanding how physicochemical, formulation and physiological factors affect oral drug absorption. The purpose of this study was to develop a drug specific physiologically based pharmacokinetic model that will allow mechanistic interpretation of oral absorption from dosage forms exhibiting different in vitro and different in vivo performance (i.e. immediate release and sustained release tablets) and identification of bioperformance dissolution testing. Ibuprofen was chosen to be used for the "proof of concept" considering it is well characterised and the necessary physicochemical, biopharmaceutical and pharmacokinetic properties for model development could be found in the literature. Gastrointestinal simulation technology implemented in Simcyp (R) was successful in estimating ibuprofen oral absorption. The developed model exhibited good generalisation ability for the dosage forms studied. The obtained results indicate that the model was sensitive to input kinetics represented by the in vitro drug release profiles obtained under various dissolution conditions. According to the obtained results, reciprocating cylinder apparatus with biorepresentative change in media pH might be considered as bioperformance dissolution in the case of the two ibuprofen SR products studied. These results further justify the use of integrated in vitro-in vivo-in silico approach in estimating bioperformance of oral solid dosage forms.", publisher = "Elsevier Science BV, Amsterdam", journal = "European Journal of Pharmaceutical Sciences", title = "In vitro-in vivo-in silico approach in biopharmaceutical characterization of ibuprofen IR and SR tablets", volume = "75", pages = "151-159", doi = "10.1016/j.ejps.2015.03.027" }
Beloica, S., Cvijić, S., Bogataj, M.,& Parojčić, J.. (2015). In vitro-in vivo-in silico approach in biopharmaceutical characterization of ibuprofen IR and SR tablets. in European Journal of Pharmaceutical Sciences Elsevier Science BV, Amsterdam., 75, 151-159. https://doi.org/10.1016/j.ejps.2015.03.027
Beloica S, Cvijić S, Bogataj M, Parojčić J. In vitro-in vivo-in silico approach in biopharmaceutical characterization of ibuprofen IR and SR tablets. in European Journal of Pharmaceutical Sciences. 2015;75:151-159. doi:10.1016/j.ejps.2015.03.027 .
Beloica, Sofija, Cvijić, Sandra, Bogataj, Marija, Parojčić, Jelena, "In vitro-in vivo-in silico approach in biopharmaceutical characterization of ibuprofen IR and SR tablets" in European Journal of Pharmaceutical Sciences, 75 (2015):151-159, https://doi.org/10.1016/j.ejps.2015.03.027 . .